BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25232778)

  • 1. Caesarean section and hospitalization for respiratory syncytial virus infection: a population-based study.
    Kristensen K; Fisker N; Haerskjold A; Ravn H; Simões EA; Stensballe L
    Pediatr Infect Dis J; 2015 Feb; 34(2):145-8. PubMed ID: 25232778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Hospitalization for Respiratory Syncytial Virus Infection: A Population-based Cohort Study of Danish Children.
    Haerskjold A; Kristensen K; Kamper-Jørgensen M; Nybo Andersen AM; Ravn H; Graff Stensballe L
    Pediatr Infect Dis J; 2016 Jan; 35(1):61-5. PubMed ID: 26398871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The causal direction in the association between respiratory syncytial virus hospitalization and asthma.
    Stensballe LG; Simonsen JB; Thomsen SF; Larsen AM; Lysdal SH; Aaby P; Kyvik KO; Skytthe A; Backer V; Bisgaard H
    J Allergy Clin Immunol; 2009 Jan; 123(1):131-137.e1. PubMed ID: 19130934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cesarean section and disease associated with immune function.
    Kristensen K; Henriksen L
    J Allergy Clin Immunol; 2016 Feb; 137(2):587-90. PubMed ID: 26371844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study.
    Kristensen K; Hjuler T; Ravn H; Simões EA; Stensballe LG
    Clin Infect Dis; 2012 Mar; 54(6):810-7. PubMed ID: 22247121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
    van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
    J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study.
    Thomsen SF; van der Sluis S; Stensballe LG; Posthuma D; Skytthe A; Kyvik KO; Duffy DL; Backer V; Bisgaard H
    Am J Respir Crit Care Med; 2009 Jun; 179(12):1091-7. PubMed ID: 19286626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of birth month on the risk of respiratory syncytial virus hospitalization in the first year of life in the United States.
    Lloyd PC; May L; Hoffman D; Riegelman R; Simonsen L
    Pediatr Infect Dis J; 2014 Jun; 33(6):e135-40. PubMed ID: 24445838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.
    Singleton R; Dooley L; Bruden D; Raelson S; Butler JC
    Pediatr Infect Dis J; 2003 Jun; 22(6):540-5. PubMed ID: 12799511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective cesarean delivery as a predisposing factor of respiratory syncytial virus bronchiolitis in children.
    Shang X; Liabsuetrakul T; Sangsupawanich P; Xia X; He P; Cao H
    J Med Assoc Thai; 2014 Aug; 97(8):827-34. PubMed ID: 25345258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study.
    Stensballe LG; Hjuler T; Andersen A; Kaltoft M; Ravn H; Aaby P; Simoes EA
    Clin Infect Dis; 2008 Apr; 46(8):1165-71. PubMed ID: 18444851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life.
    Escobar GJ; Ragins A; Li SX; Prager L; Masaquel AS; Kipnis P
    Arch Pediatr Adolesc Med; 2010 Oct; 164(10):915-22. PubMed ID: 20921348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
    Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Tachypnea of the Newborn Is Associated With an Increased Risk of Hospitalization Due to Respiratory Syncytial Virus Bronchiolitis.
    Heinonen S; Süvari L; Gissler M; Pitkänen O; Andersson S; Helve O
    Pediatr Infect Dis J; 2019 Apr; 38(4):419-421. PubMed ID: 30882737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.
    Lacaze-Masmonteil T; Rozé JC; Fauroux B;
    Pediatr Pulmonol; 2002 Sep; 34(3):181-8. PubMed ID: 12203846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study.
    Yi H; Lanctôt KL; Bont L; Bloemers BL; Weijerman M; Broers C; Li A; Kiss A; Mitchell I; Paes B;
    Pediatrics; 2014 Jun; 133(6):1031-7. PubMed ID: 24799541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study.
    Zachariah P; Ruttenber M; Simões EA
    J Pediatr; 2012 May; 160(5):827-31.e1. PubMed ID: 22177993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.